Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1967 Nov 30;126(6):1027–1048. doi: 10.1084/jem.126.6.1027

COMPLEMENT AS A MEDIATOR OF INFLAMMATION

III. PURIFICATION OF THE ACTIVITY WITH ANAPHYLATOXIN PROPERTIES GENERATED BY INTERACTION OF THE FIRST FOUR COMPONENTS OF COMPLEMENT AND ITS IDENTIFICATION AS A CLEAVAGE PRODUCT OF C'3

W Dias da Silva 1, John W Eisele 1, Irwin H Lepow 1
PMCID: PMC2138425  PMID: 6069927

Abstract

Purified preparations of human C'1 esterase, C'4, C'2, C'3, and C'5 were labeled with 125I. Reaction mixtures were prepared containing a single labeled component and other unlabled components. After incubation at 37°C for 10 min at pH 7.4 in the presence of 5 x 10–4 M Mg2+, they were adjusted to pH 3.5 and subjected to sucrose density gradient ultracentrifugation and gel filtration at pH 3.5. In all cases, an activity capable of contracting guinea pig ileum with tachyphylaxis was obtained in low molecular weight fractions. However, these fractions were labeled only when 125I-C'3 was employed, indicating that biological activity was associated with a cleavage product of C'3. This fragment has been designated F(a)C'3 in a nomenclature consistent with that of immunoglobulin degradation products. The much larger, residual portion of the C'3 molecule has been designated F(b)C'3. The biochemical characteristics of generation of F(a)C'3 were consistent with a mechanism involving action of C'1 esterase on C'4 and C'2, activation of C'2, and cleavage of C'3. F(a)C'3 had a molecular weight by gel filtration techniques of 6800 or less. It was thermostable and susceptible to inactivation by endo- and exopeptidases. The isolated fragment possessed all of the biological properties of unfractionated mixtures of C'1 esterase, C'4, C'2, and C'3. In addition to contraction of guinea pig ileum, these included failure to contract rat uterus, enhancement of vascular permeability in guinea pig skin, degranulation of mast cells in guinea pig mesentery, and release of histamine from rat peritoneal mast cells. F(a)C'3 did not cross-desensitize guinea pig ileum to rat agar anaphylatoxin and vice versa. The existence of different protein fragments with anaphylatoxin properties has been discussed. Distinctive characteristics of F(a)C'3 from classical anaphylatoxin generated by treatment of fresh rat serum with agar have been indicated.

Full Text

The Full Text of this article is available as a PDF (1.2 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARCHER G. T. Release of histamine from mast cells by antigen-antibody reactions in vitro. Aust J Exp Biol Med Sci. 1960 Apr;38:147–151. doi: 10.1038/icb.1960.16. [DOI] [PubMed] [Google Scholar]
  2. Andrews P. The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J. 1965 Sep;96(3):595–606. doi: 10.1042/bj0960595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dalmasso A. P., Müller-Eberhard H. J. Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement. J Immunol. 1966 Nov;97(5):680–685. [PubMed] [Google Scholar]
  4. Dias Da Silva W., Lepow I. H. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J Exp Med. 1967 May 1;125(5):921–946. doi: 10.1084/jem.125.5.921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dias da Silva W., Lepow I. H. Anaphylatoxin formation by purified human C'1 esterase. J Immunol. 1965 Dec;95(6):1080–1089. [PubMed] [Google Scholar]
  6. FELDBERG W., TALESNIK J. Reduction of tissue histamine by compound 48/80. J Physiol. 1953 Jun 29;120(4):550–568. doi: 10.1113/jphysiol.1953.sp004917. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. HAINES A. L., LEPOW I. H. STUDIES ON HUMAN C'1-ESTERASE. I. PURIFICATION AND ENZYMATIC PROPERTIES. J Immunol. 1964 Mar;92:456–467. [PubMed] [Google Scholar]
  8. HELMKAMP R. W., GOODLAND R. L., BALE W. F., SPAR I. L., MUTSCHLER L. E. High specific activity iodination of gamma-globulin with iodine-131 monochloride. Cancer Res. 1960 Nov;20:1495–1500. [PubMed] [Google Scholar]
  9. Jensen J. Anaphylatoxin in its relation to the complement system. Science. 1967 Mar 3;155(3766):1122–1123. doi: 10.1126/science.155.3766.1122. [DOI] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. MARTIN R. G., AMES B. N. A method for determining the sedimentation behavior of enzymes: application to protein mixtures. J Biol Chem. 1961 May;236:1372–1379. [PubMed] [Google Scholar]
  12. MILES A. A., WILHELM D. L. Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. I. An activable permeability factor and its inhibitor in guinea-pig serum. Br J Exp Pathol. 1955 Feb;36(1):71–81. [PMC free article] [PubMed] [Google Scholar]
  13. MOTA I. Action of anaphylactic shock and anaphylatoxin on mast cells and histamine in rats. Br J Pharmacol Chemother. 1957 Dec;12(4):453–456. doi: 10.1111/j.1476-5381.1957.tb00164.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. MOTA I., da SILVA W. The anti-anaphylactic and histamine-releasing properties of the antihistamines. Their effect on the mast cells. Br J Pharmacol Chemother. 1960 Sep;15:396–404. doi: 10.1111/j.1476-5381.1960.tb01262.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. MUELLER-EBERHARD H. J., BIRO C. E. ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1963 Sep 1;118:447–466. doi: 10.1084/jem.118.3.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MUELLER-EBERHARD H. J., LEPOW I. H. C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 May 1;121:819–833. doi: 10.1084/jem.121.5.819. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Müller-Eberhard H. J., Polley M. J., Calcott M. A. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J Exp Med. 1967 Feb 1;125(2):359–380. doi: 10.1084/jem.125.2.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. NAFF G. B., PENSKY J., LEPOW I. H. THE MACROMOLECULAR NATURE OF THE FIRST COMPONENT OF HUMAN COMPLEMENT. J Exp Med. 1964 Apr 1;119:593–613. doi: 10.1084/jem.119.4.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. NILSSON U. R., MUELLER-EBERHARD H. J. ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT. J Exp Med. 1965 Aug 1;122:277–298. doi: 10.1084/jem.122.2.277. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. RATNOFF O. D., LEPOW I. H. COMPLEMENT AS A MEDIATOR OF INFLAMMATION. ENHANCEMENT OF VASCULAR PERMEABILITY BY PURIFIED HUMAN C'1 ESTERASE. J Exp Med. 1963 Nov 1;118:681–698. doi: 10.1084/jem.118.5.681. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. SMINK R. D., Jr, ABERNETHY R. W., RATNOFF O. D., LEPOW I. H. ENHANCEMENT OF VASCULAR PERMEABILITY BY MIXTURES OF C'1 ESTERASE AND NORMAL SERUM. Proc Soc Exp Biol Med. 1964 Jun;116:280–283. doi: 10.3181/00379727-116-29226. [DOI] [PubMed] [Google Scholar]
  22. STEGEMANN H., VOGT W., FRIEDBERG K. D. UBER DIE NATUR DES ANAPHYLATOXINS. Hoppe Seylers Z Physiol Chem. 1964;337:269–276. doi: 10.1515/bchm2.1964.337.1.269. [DOI] [PubMed] [Google Scholar]
  23. Vogt W., Schmidt G. Formation of anaphylatoxin in rat plasma, a specific enzymic process. Biochem Pharmacol. 1966 Jul;15(7):905–914. doi: 10.1016/0006-2952(66)90167-5. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES